A heterozygous loss-of-function mutation in the PKC-β gene was identified in colon cancer, and restoration of wild-type enzyme activity decreased anchorage-dependent growth of tumour cells in vitro [43]. Here, PRKCB is linked to malignant colon neoplasm.